Table 2. Mutations associated with intradural extramedullary (IDEM) tumors.
Tumor | Gene | Locus | Grade | Molecular finding |
---|---|---|---|---|
Meningioma | – | 22 | I–III | Most consistently reported finding of spinal meningioma |
MMP9 | 20q11.2 | I–III | Overexpressed in spinal meningiomas via IHC | |
SMARCE1 | 17q21.2 | I–III | Familial spinal meningiomas in patients without NF2; all clear-cell histology | |
Schwannoma | NF2 | 22q12 | – | Germline inactivating mutations |
SMARCB1 | 22q11 | – | Germline alteration in ~50% of familial and ~10% of sporadic schwannomatosis cases | |
LZTR1 | 22q11 | – | Germline LoF in majority of schwannomatosis cases lacking mutations in SMARCB1, but with loss of chromosome 22q in tumors | |
ARID1A | 1p36.11 | – | Recurrent somatic mutations in sporadic schwannomas, identified by WES | |
ARID1B | 6q25.3 | – | ||
DDR1 | 6p21.33 | – | ||
SH3PXD2A-HTRA1 | – | – | Recurrent fusion in 10% of sporadic schwannoma |
IHC, immunohistochemistry; LoF, loss-of-function; WES, whole-exome sequencing.